BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 16952661)

  • 1. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.
    Evans JG; Spiess PE; Kamat AM; Wood CG; Hernandez M; Pettaway CA; Dinney CP; Pisters LL
    J Urol; 2006 Oct; 176(4 Pt 1):1463-7. PubMed ID: 16952661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chylous ascites following surgical treatment for wilms tumor.
    Weiser AC; Lindgren BW; Ritchey ML; Franco I
    J Urol; 2003 Oct; 170(4 Pt 2):1667-9; discussion 1669. PubMed ID: 14501687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chylous ascites in gynecologic malignancies: cases report and literature review.
    Baiocchi G; Faloppa CC; Araujo RL; Fukazawa EM; Kumagai LY; Menezes AN; Badiglian-Filho L
    Arch Gynecol Obstet; 2010 Apr; 281(4):677-81. PubMed ID: 19685063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.
    Nash PA; Leibovitch I; Foster RS; Bihrle R; Rowland RG; Donohue JP
    J Urol; 1998 Mar; 159(3):707-10. PubMed ID: 9474130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
    J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Tal R; Sheinfeld J
    J Urol; 2006 Nov; 176(5):1996-9; discussion 1999. PubMed ID: 17070234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer.
    Baniel J; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1993 Nov; 150(5 Pt 1):1422-4. PubMed ID: 8411415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylous ascites following para-aortic lymphadenectomy: a case report.
    Boran N; Cil AP; Tulunay G; Ozgul N; Kose MF
    Gynecol Oncol; 2004 Jun; 93(3):711-4. PubMed ID: 15196870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphorrhea after retroperitoneal lymphadenectomy for testicular cancer].
    Villavicencio H; Martínez E; Solé F; Germá JR
    Actas Urol Esp; 1986; 10(3):221-4. PubMed ID: 3090863
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Chylous Ascites with Peritoneovenous Shunt (Denver Shunt) following Retroperitoneal Lymph Node Dissection in Patients with Urological Malignancies: Update of Efficacy and Predictors of Complications.
    Yarmohammadi H; Schilsky J; Durack JC; Brody LA; Asenbaum U; Velayati S; Santos E; Gonzalez-Aguirre AJ; Erinjeri JP; Petre N; Solomon SB; Sheinfeld J; Getrajdman GI
    J Urol; 2020 Oct; 204(4):818-823. PubMed ID: 32364837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
    Beck SD; Foster RS; Bihrle R; Koch MO; Wahle GR; Donohue JP
    J Urol; 2001 May; 165(5):1517-20. PubMed ID: 11342909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB; Steele GS; Richie JP
    J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The conservative treatment of postoperative chylous ascites in gynecologic cancers: four case reports.
    Var T; Güngor T; Tonguc E; Ozdener T; Mollamahmutoğlu L
    Arch Gynecol Obstet; 2012 Mar; 285(3):849-51. PubMed ID: 21837421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial impact of a clinical care pathway in patients with testicular cancer undergoing retroperitoneal lymph node dissection.
    Chang SS; Smith JA; Girasole C; Baumgartner RG; Roth BJ; Cookson MS
    J Urol; 2002 Jul; 168(1):87-92. PubMed ID: 12050498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chylous ascites following retroperitoneal lymphadenectomy for testes cancer.
    Link RE; Amin N; Kavoussi LR
    Nat Clin Pract Urol; 2006 Apr; 3(4):226-32; quiz 233. PubMed ID: 16607371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postsurgical chylous ascites: case report and literature review].
    Olivar Roldán J; Fernández Martínez A; Martínez Sancho E; Díaz Gómez J; Martín Borge V; Gómez Candela C
    Nutr Hosp; 2009; 24(6):748-50. PubMed ID: 20049381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.
    Spiess PE; Brown GA; Liu P; Tu SM; Tannir NM; Evans JG; Kamat AM; Kassouf W; Pisters LL
    J Urol; 2007 Jan; 177(1):131-8. PubMed ID: 17162023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.